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in an autosomal recessive spinocerebellar ataxia
patient
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Background: Spinocerebellar ataxias (SCAs) are heterogeneous diseases characterized by progressive cerebellar
ataxia associated with dysarthria, oculomotor abnormalities, and mental impairment. To identify the causative gene,
we performed exome sequencing on a Japanese patient clinically diagnosed with recessive SCA.
Method: The patient is a 37-year-old Japanese woman with consanguineous parents. The head magnetic resonance
imaging (MRI) showed cerebellar atrophy and T1 low/T2 high intensity at the bilateral inferior olives. Single-nucleotide
polymorphism (SNP) genotyping and next-generation sequencing were performed, and the variants obtained were
filtered and prioritized.
Results: After these manipulations, we identified a homozygous nonsense mutation of the TTC19 gene (p.Q277*).
TTC19 has been reported to be a causative gene of a neurodegenerative disease in Italian and Portuguese families and
to be involved in the pathogenesis of mitochondrial respiratory chain complex III (cIII) deficiency. This report is the first
description of a TTC19 mutation in an Asian population. Clinical symptoms and neuroimaging are consistent with
previous reports. The head MRI already showed abnormal features four years before her blood lactate and pyruvate
levels were elevated.
Conclusions: We should consider the genetic analysis of TTC19 when we observe such characteristic MRI
abnormalities. Genes associated with mitochondrial function cause many types of SCAs; the mutation we identified
should help to elucidate the pathology of these disorders.
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TTC19Background
Spinocerebellar ataxias (SCAs) are genetically, clinically
and pathologically heterogeneous diseases characterized
by progressive cerebellar ataxia variably associated with
dysarthria, oculomotor abnormalities, epilepsy, and men-
tal impairment. Neuronal loss is observed in cerebellum
and brainstem pathologies, and neuroimaging demon-
strates the atrophy of those regions. These pathologies can
be caused by autosomal dominant, autosomal recessive,
and X-linked mutations, and many of the dominant* Correspondence: morino@hiroshima-u.ac.jp
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stated.mutations are caused by CAG triplet repeat expansion.
Thirteen recessive SCAs (numbered as SCAR1-13) have
been reported, and causative genes have been identified
for 7 of them.
In recent years, it has been reported that cases of neu-
rodegenerative disease associated with atrophy of the
cerebellar vermis and the cerebral cortex are caused by
homozygous nonsense mutations of TTC19 [GenBank:
NM_017775] in Italian and Portuguese families [1,2].
TTC19 encodes tetratricopeptide repeat domain 19
which consists of 380 amino acids. TTC19 is involved in
the assembly and activity of ubiquinol-cytochrome c re-
ductase (mitochondrial respiratory chain complex III,
E.C.1.10.2.2) (MRC cIII). Mammalian cIII consists of
11 subunits [3]. Among them, cytochrome b is the onlyLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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are encoded by nuclear DNA. Mutations in BCS1L [4],
one of the assembly factors, are involved in most cases of
cIII deficiency. According to the report mentioned above
[1], the TTC19 protein is another assembly factor of cIII,
and nonsense mutations in its gene cause the functional
loss of cIII and, consequently, neurodegenerative disease.
Here, we performed exome sequencing on a patient
clinically diagnosed with recessive SCA and identified a
novel TTC19 mutation. Her main symptoms were cere-
bellar ataxia and mental impairment, and magnetic res-
onance imaging (MRI) results were similar to those
described in previous reports [1,2].
Methods
Patient
We performed exome sequencing on a Japanese woman
born to consanguineous parents who were first cousins
(Figure 1A). The 37-year-old woman noticed dysarthria
at age 31. She exhibited brisk tendon reflex, ataxic gait,
severe truncal ataxia, horizontal nystagmus, intellectual
impairment, and pes cavus. Head MRI showed cerebellar
atrophy and T1 low/T2 high intensity at the bilateral in-
ferior olives at the age of 33 (Figure 2). Her blood lactic
acid (14.0 mg/dl, normal range: 3–17 mg/dl) and pyruvic
acid levels (0.62 mg/dl, normal range: 0.30-0.94 mg/dl)
were normal at the age of 35 but were elevated at the
age of 37 (lactic acid: 24.9 mg/dl, pyruvic acid: 1.63 mg/dl).
A muscle biopsy was not performed because the patient
declined consent. She began to use a wheelchair when she
was 34 years old.Figure 1 Pedigree chart, homozygosity mapping, and capillary seque
first cousins. No other members of the family have exhibited the same sym
on chromosomes 3, 17, and 21. C. Patient has a homozygous nonsense muIdentity by descent (IBD)
SNP genotyping was performed using the Genome-Wide
Human SNP Array 6.0 (Affymetrix, Santa Clara, CA,
USA). Identity by descent (IBD) was calculated using
Homozygosity Mapping software [5].
Exome sequencing
Genomic DNA (gDNA) was extracted from the peripheral
lymphocytes of the patients. gDNA libraries were pre-
pared using the SeqCap EZ Human Exome Library v2.0
(Roche NimbleGen, Madison, WI, USA). Sequencing was
performed with 100-bp paired-end reads on a HiSeq2000
sequencer (Illumina, San Diego, CA, USA). We used
BWA (http://bio-bwa.sourceforge.net/) [6] for alignment
and mapping, Samtools (http://samtools.sourceforge.net/)
[7] and Picard (http://picard.sourceforge.net/) for SAM/
BAM handling, GATK (http://www.broadinstitute.org/
gatk/) [8] and Samtools for variant calls, and Annovar
(http://www.openbioinformatics.org/annovar/) [9] for an-
notation. Functional predictions due to amino acid
changes were estimated using PolyPhen2 (http://genetics.
bwh.harvard.edu/pph2/) [10], SIFT (http://sift.bii.a-star.edu.
sg/) [11], and Mutation Taster (http://www.mutationtaster.
org/index.html) [12]. We evaluated copy number variants
(CNVs) from exome reads using CoNIFER (http://conifer.
sourceforge.net/) [13]. Control exome sequences were ob-
tained from Japanese patients undergoing exome analysis
for diseases other than SCAs. All reported genomic coordi-
nates were in GRCh37/hg19. The identified mutations were
validated with a standard polymerase chain reaction (PCR)-
based amplification followed by sequence analysis with anncing. A. The patient was born to consanguineous parents who were
ptoms. B. Black bar indicates IBD. Relatively long segments of IBD exist
tation of TTC19 (c.829C > T, p.Q277*).
Figure 2 Brain MRI. Left is T1 weighted sagittal image, and right is T2 weighted axial image. Cerebellar atrophy was observed. Bilateral
inferior olives showed T2 high intensity (arrowheads).







Not found in public DBs 8,699
AA substitution 873
Homozygote 76
Not found in in-house DB 20
IBD 4
Nonsense 1
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gies, Carlsbad, CA, USA). Additionally, we enrolled 180
normal Japanese controls without any neurological disorder
and screened them for this mutation with the capillary se-
quencer. The research procedure was approved by the eth-
ics committee of Hiroshima University. All examinations
were performed after obtaining written informed consent
from the patient and control cohort for publication of this
case report and any accompanying images.
Results
IBD
The total length of IBD is 136,462,257 bp, and the percent-
age of IBD is 5.2%. There are 1,283 genes in the IBD regions
on the RefSeq database. ATXN3 and PRKCG, causative
genes of SCA3 and SCA14 respectively, are located in the
IBD regions, but there are no known associated genes with
recessive SCAs. Relatively long segments of IBD exist on
chromosomes 3, 17, and 21 (Figure 1B). IBD analysis was
used to subsequently refine the candidates.
Exome sequencing
The results of the exome sequencing are shown in Table 1.
There were 100,134,744 total reads and 90,942,725 mapped
reads, and the mean coverage was 90. We obtained 98,277
variants from GATK and Samtools. We used filtering cri-
teria consisting of zygosity, genomic position, function,
open databases (dbSNP build 135, 1000 genomes and ESP
5400), regions of IBD, and population-matched controls,
which resulted in several sequence variants for each
sample. There were no variant candidates in the
known causative genes of SCDs. From the results of
filtering, 4 candidate mutations were identified in the
genes of NPM2, PDLIM2,TTC19 and ZSCAN4 (Additional
file 1: Table S1). One of these mutations was a homozy-
gous nonsense mutation of the TTC19 gene (GenBank:
NM_017775:c.829C > T, p.Q277*), which was the mostlikely candidate to cause SCAs. The presence of this
mutation was confirmed using capillary sequencing
(Figure 1C). This TTC19 mutation was identified in a
heterozygous state in one of the 145 population-matched
disease control samples but not in the 180 normal control
samples. The heterozygous sample was an odontopathy
patient without any neurological deficit, and the CNV data
indicated no deletions or duplications of the TTC19 gene.
Discussion
This report describes a TTC19 mutation causing ataxia
and metal impairment in an Asian population. Accord-
ing to the previous reports, all patients harbored homo-
zygous nonsense mutations in TTC19, and head MRI
showed characteristic findings including cerebellar atro-
phy and abnormal intensity at the bilateral inferior olives
[1,2]. Our patient had a novel homozygous nonsense
mutation of TTC19, and head MRI were quite similar to
those previously reported. The TTC19 protein is an as-
sembly factor of MRC cIII, which transfers electrons
from coenzyme Q to cytochrome c. TTC19 mutations
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creased levels of blood lactic acid. Simultaneously, mag-
netic resonance spectroscopy shows a lactic peak [1].
While the patient’s head MRI revealed abnormal fea-
tures, her blood lactic acid and pyruvic acid levels were
normal. However, these acid levels were elevated 6 years
after the disease onset. One should consider mitochon-
drial abnormality and perform genetic analysis when ob-
serving such MRI characteristics. In the previous studies,
no TTC19 protein was detected and the TTC19 transcript
level was markedly reduced in samples with TTC19 muta-
tions [1,2]. However, further analysis could not be per-
formed because we could not obtain any additional
clinical specimens from the patient other than gDNA.
We identified one heterozygote for this mutation in
control samples. This result indicates an allele frequency
of 0.14%, but this mutation was not included in public
SNP databases such as dbSNP and 1000 genomes. There-
fore, the actual frequency of the mutation is even lower,
which does not rule out the possibility that the mutation
is a cause of recessive inheritance of the symptoms ob-
served in the patient.
Neurodegeneration caused by mutations of TTC19
are classified as mitochondrial complex III deficiencies
(MC3DNs), including MC3DN1 [MIM:124000] [4],
which is associated with compound heterozygous or
homozygous mutations of the BCS1L gene. Clinical
symptoms of MC3DN are varied, but in reports on
mutations of TTC19, many cases exhibit neurological
disorders in adulthood, and some cases present both
hemiplegia and cerebellar ataxia. Pyramidal signs were not
observed in our case, but intellectual dysfunction was ob-
served. As shown in previous reports, TTC19 p.Q173Rfs*4,
p.L219* [1] and p.A200Afs*8 [2] are located between the
first and the second TPR domains, but p.Q277*, the novel
substitution we identified is located between the second
and third domains, accordingly deleting half of the TPR
domains. Notably, all these mutations are nonsense
mutations. Clinical symptoms were mild compared
with the symptoms from previously reported cases, but
determining whether mutations are associated with
clinical symptoms may require a longer observation of
our patient’s clinical course and the accumulation of
more cases.
Regarding other variant candidates, the NPM2 variant
was predicted as benign by PolyPhen-2, Mutation Taster,
and SIFT; the ZSCAN4 variant was predicted as dam-
aging only by SIFT. Thus, it is unlikely that NPM2 or
ZSCAN4 is the causative mutation. The PDLIM2 variant
was predicted as disease causing by Mutation Taster and
SIFT. However, it is unlikely that PDLIM2 is the cause
of SCA because PDLIM2 is expressed at low levels in
the brain and is speculated to be associated with the in-
flammatory response of T helper 17 cells [14,15].Several studies have implicated mutations in genes in-
volved in mitochondrial function as a cause of SCAs
[16]. For example, coenzyme Q10 deficiencies are known
as diseases that lead to ataxia associated with MRC dys-
function. Thus far, there have been 6 subtypes of coenzyme
Q10 deficiencies, including COQ10D4 [MIM:612016],
which is also referred to as SCAR9 and is caused by homo-
zygous or compound heterozygous mutations in CABC1
[17]. In addition to cerebellar ataxia, coenzyme Q10 defi-
ciencies show hypotonia, epilepsy, and muscular symp-
toms. Thus, mutations in the genes causing mitochondrial
dysfunction show broad spectrum of clinical outcome.Conclusions
In conclusion, using exome sequencing, we identified a
new TTC19 mutation that is the cause of an autosomal
recessive SCA. Notably, our case showed abnormal MRI
findings before we detected a metabolic disorder. Genes
associated with mitochondrial function cause many types
of SCAs, and we should consider the genetic analysis of
mitochondria-related genes when observing such char-
acteristic clinical features including MRI abnormalities.Additional file
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